Biotecnol Inc., PolyTherics deal

Biotecnol and PolyTherics partnered to develop multi-specific Tribody drug conjugates to

Read the full 111 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE